Javascript must be enabled to continue!
Immunohistochemical study of CD15 expression in CD30+ classical Hodgkin's lymphoma
View through CrossRef
defined B-cell neoplasm that includes two distinct types of disease, classical and nodular lymphocyte-predominant. Aim of the study: To evaluate the immunohistochemical expression of CD15 in CD30+ classical Hodgkin’s lymphoma. Patients and Methods: This retrospective study included revision of 52 lymph nodes specimens from patients newly diagnosed with HL from January 2005 to September 2010.These samples were collected from Al-Yarmouk Teaching Hospital, Baghdad Medical City and Al-Atheer private laboratory. Only well-preserved samples that stood a retrospective confirmatory morphological revision and revealed IHC CD30 stain {from DAKO} positive reactivity were included in this study. All biopsies were formalin-fixed and paraffin embedded. A 4 micron sections obtained and stained with hematoxylin and eosin and CD15 monoclonal antibody {from DAKO} according to thekit-included instructions.Results: This study revealed that the CD15 positive classical HL are 24 (75%), 10 (100%), 6 (100%) and 0 (0%) for MC, NS, LD and LR respectively.Conclusions: All cases of cHD should undergo immunophenotypic analysis for CD15 in addition to CD30 antigen.
University of A-Qadisiyah
Title: Immunohistochemical study of CD15 expression in CD30+ classical Hodgkin's lymphoma
Description:
defined B-cell neoplasm that includes two distinct types of disease, classical and nodular lymphocyte-predominant.
Aim of the study: To evaluate the immunohistochemical expression of CD15 in CD30+ classical Hodgkin’s lymphoma.
Patients and Methods: This retrospective study included revision of 52 lymph nodes specimens from patients newly diagnosed with HL from January 2005 to September 2010.
These samples were collected from Al-Yarmouk Teaching Hospital, Baghdad Medical City and Al-Atheer private laboratory.
Only well-preserved samples that stood a retrospective confirmatory morphological revision and revealed IHC CD30 stain {from DAKO} positive reactivity were included in this study.
All biopsies were formalin-fixed and paraffin embedded.
A 4 micron sections obtained and stained with hematoxylin and eosin and CD15 monoclonal antibody {from DAKO} according to thekit-included instructions.
Results: This study revealed that the CD15 positive classical HL are 24 (75%), 10 (100%), 6 (100%) and 0 (0%) for MC, NS, LD and LR respectively.
Conclusions: All cases of cHD should undergo immunophenotypic analysis for CD15 in addition to CD30 antigen.
Related Results
Exploring the Association between Lymphoma and Inflammatory Bowel Disease in an Inner-City Academic Institution
Exploring the Association between Lymphoma and Inflammatory Bowel Disease in an Inner-City Academic Institution
Introduction:
The incidence of lymphoma has been increasing over the past several decades, with data showing an estimated annual percentage change of 0.56%. There...
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Abstract
Introduction
Non-Hodgkin lymphoma (NHL) of the thyroid, a rare malignancy linked to autoimmune disorders, is poorly understood in terms of its pathogenesis and treatment o...
Liệu pháp điều trị trúng đích trong u lympho không Hodgkin
Liệu pháp điều trị trúng đích trong u lympho không Hodgkin
U lympho là bệnh lý ác tính dòng lympho thường gặp nhất trong huyết học, bao gồm u lympho Hodgkin và u lympho không Hodgkin. Trong đó, u lympho không Hodgkin chiếm đa số (80 - 85%)...
Macrophages and Mast Cells Infiltration Are Biomarkers of Primary Refractory Hodgkin's Lymphoma
Macrophages and Mast Cells Infiltration Are Biomarkers of Primary Refractory Hodgkin's Lymphoma
Abstract
Abstract 3881
Classical Hodgkin's lymphoma is a highly curable lymphoma and about 80% of patients can be cured with modern treatment strategi...
Real-World Results of Brentuximab Vedotin Containing Regimens in CD30 Positive Lymphoma: A Single-Center Retrospective Study
Real-World Results of Brentuximab Vedotin Containing Regimens in CD30 Positive Lymphoma: A Single-Center Retrospective Study
Objective:
The objective of this retrospective study was to assess the effectiveness and safety of Brentuximab Vedotin (BV) in CD30-positive lymphoma.
...
Kikuchi-Fujimoto Disease Coexistent with Papillary Thyroid Carcinoma: A Report of Two Cases
Kikuchi-Fujimoto Disease Coexistent with Papillary Thyroid Carcinoma: A Report of Two Cases
Abstract
Introduction
Kikuchi-Fujimoto Disease (KFD), characterized by histiocytic necrotizing lymphadenitis, is a rare condition of unknown etiology. Diagnosis is dependent on lym...

